Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Berchou

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|January 21, 2000
Maximizing the benefit of pharmacotherapy in Parkinson's diseaseR C Berchou
American Journal of Hospital Pharmacy|October 1, 1982
Effect of a consultant pharmacist on medication use in an institution for the mentally retardedR C Berchou
Brain Injury|July 1, 1987
Post-traumatic epilepsy following head injuryM A Guidice, R C Berchou
Neurology|November 1, 1981
Clorazepate therapy for refractory seizuresR C Berchou, E A Rodin, M E Russell
Annals of Clinical Biochemistry|July 1, 1979
Accuracy of serum anticonvulsant measurements. A comparison of enzyme multiplied immunoassay technique and gas-liquid chromatographyR C Berchou, R A Lodi, J A Sherman
Research Communications in Chemical Pathology and Pharmacology|September 1, 1992
Diminished mephobarbital anticonvulsant action following diphenhydramine pretreatmentD L Lourwood, R C Berchou, R T Louis-Ferdinand
Clinical Pharmacology and Therapeutics|June 1, 1990
Pharmacokinetic evaluation of erythromycin and caffeine administered with bromocriptineM V Nelson, R C Berchou, D Kareti, et al.
Archives of Neurology|April 1, 1981
Dissociation between free and bound phenytoin levels in presence of valproate sodiumE A Rodin, G DeSousa, D Haidukewych, et al.
Neurology|January 1, 1990
Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's diseaseM V Nelson, R C Berchou, P A LeWitt, et al.
Neurology|November 1, 1989
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studiesP A LeWitt, M V Nelson, R C Berchou, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|January 21, 2000
Maximizing the benefit of pharmacotherapy in Parkinson's diseaseR C Berchou
American Journal of Hospital Pharmacy|October 1, 1982
Effect of a consultant pharmacist on medication use in an institution for the mentally retardedR C Berchou
Brain Injury|July 1, 1987
Post-traumatic epilepsy following head injuryM A Guidice, R C Berchou
Neurology|November 1, 1981
Clorazepate therapy for refractory seizuresR C Berchou, E A Rodin, M E Russell
Annals of Clinical Biochemistry|July 1, 1979
Accuracy of serum anticonvulsant measurements. A comparison of enzyme multiplied immunoassay technique and gas-liquid chromatographyR C Berchou, R A Lodi, J A Sherman
Research Communications in Chemical Pathology and Pharmacology|September 1, 1992
Diminished mephobarbital anticonvulsant action following diphenhydramine pretreatmentD L Lourwood, R C Berchou, R T Louis-Ferdinand
Clinical Pharmacology and Therapeutics|June 1, 1990
Pharmacokinetic evaluation of erythromycin and caffeine administered with bromocriptineM V Nelson, R C Berchou, D Kareti, et al.
Archives of Neurology|April 1, 1981
Dissociation between free and bound phenytoin levels in presence of valproate sodiumE A Rodin, G DeSousa, D Haidukewych, et al.
Neurology|January 1, 1990
Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's diseaseM V Nelson, R C Berchou, P A LeWitt, et al.
Neurology|November 1, 1989
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studiesP A LeWitt, M V Nelson, R C Berchou, et al.
Pageof 2